Related Experiment Videos
Who does best on CAPD? A study to identify self-care determinants
EDTNA/ERCA Journal (English Ed.)
|July 1, 1997
Summary
Patients with end-stage renal failure (ESRF) can choose between haemodialysis and continuous ambulatory peritoneal dialysis (CAPD). In the UK, about half of dialysis patients use CAPD, with the rest on haemodialysis.
Area of Science:
- Nephrology
- Renal Replacement Therapy
Background:
- End-stage renal failure (ESRF) necessitates renal replacement therapy.
- Two primary options exist: haemodialysis and continuous ambulatory peritoneal dialysis (CAPD).
Purpose of the Study:
- To outline the treatment options for individuals with end-stage renal failure.
- To present the current distribution of dialysis modalities in the United Kingdom.
Main Methods:
- Literature review of renal replacement therapies.
- Analysis of dialysis modality prevalence in the UK.
Main Results:
- Approximately 50% of UK dialysis patients are managed with CAPD.
- The remaining 50% of UK dialysis patients receive haemodialysis.
Conclusions:
- CAPD and haemodialysis are the mainstays of renal replacement therapy for ESRF.
- CAPD is utilized by a significant proportion of the UK dialysis population.